Pure Global

Smartphones Aggravating Anxiety Symptoms - Trial NCT06361342

Access comprehensive clinical trial information for NCT06361342 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Enrolling by invitation. The study focuses on Anxiety. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06361342
Enrolling by invitation
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06361342
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Smartphones Aggravating Anxiety Symptoms
Smartphones Aggravating Anxiety Symptoms: Experimental Study From Southeastern

Study Focus

Anxiety

General decrease in smartphone use

Interventional

behavioral

Sponsor & Location

Mayo Clinic

Rochester, United States of America

Timeline & Enrollment

N/A

Mar 08, 2024

Mar 01, 2025

100 participants

Primary Outcome

Change in anxiety

Summary

The goal of this study is to assess if excessive use of smartphone apps of social media can
 impact a person's mental health. The study is aimed at improving the usage of smartphones
 which might help improve the mental health of patients. The goal is not to discourage the use
 of smartphones but instead to utilize smartphones in a way that they do not impact lives.

ICD-10 Classifications

Anxiety disorder, unspecified
Other anxiety disorders
Phobic anxiety disorders
Phobic anxiety disorder, unspecified
Generalized anxiety disorder

Data Source

ClinicalTrials.gov

NCT06361342

Non-Device Trial